Breast imaging market sample copy @ http://goo.gl/HLyuZr . It is over forecast period to 2021. The market is expected to reach USD 4.14 Billion by 2021, at a CAGR of 8.5% from 2016 to 2021. A number of factors such as rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues are driving the growth of the global breast imaging market.
Breast Imaging Market categorizes the entire market into ionizing breast imaging modalities and non-ionizing breast imaging modalities based on the technical aspect of use of radiation.
The global breast imaging market holds a significant share of the medical device industry owing to rising awareness about the early screening of breast cancer. Though digital Mammography is the gold standard in the current breast imaging market, modalities such as breast MRI Scans, breast ultrasound and CTs are expected to drastically improve the breast Imaging Market scenario.
Ionizing Breast Imaging Technologies market accounted for major share of the global market in 2015, owing to their ability to detect breast cancer in early stages, thus increasing the chances of survival. Moreover, advancements in breast imaging tools facilitate faster interpretation of breast tissue and generate less false positive results as compared to MRI, which further accelerates the market growth.
The Breast screening or imaging is important for the detection of cancer cells if any present in the breast. The number of cases of breast cancer every year is rising and there is high demand for early detection of cancer in breasts by using the imaging technology. There is high scope for the Breast Imaging Market in various regions across the globe during 2016-2021.
The report segments the global MRI systems market by architecture, field strength, application, and region. High-field MRI (1.5T) accounted for the largest share of the global MRI systems market. However, the very-high-field MRI (3T) segment is expected to grow at the highest CAGR in the forecast period owing to the ongoing technological advancements in this segment. See Full Report : http://bit.ly/1EmokNI
Healthcare equipment providers are constantly seeking to make adequate preparation for an integrated diagnostic model which facilitates patient centric healthcare based on evidence.
Data Bridge Market Research analyses that The breast imaging market was valued at USD 4.03 billion in 2021 and is expected to reach USD 8.02 billion by 2029, registering a CAGR of 8.97% during the forecast period of 2022 to 2029. https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-breast-imaging-market
The global breast imaging market is estimated to garner a revenue of USD 9.0 Billion by the end of 2033 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2033.
Breast cancer remains a formidable health challenge globally, prompting relentless efforts in early detection and treatment. Amidst the array of screening modalities, molecular breast imaging (MBI) emerges as a promising technique, offering enhanced sensitivity in detecting breast abnormalities. As the healthcare landscape evolves, it becomes crucial to delve into the molecular breast imaging market, analyzing its current state, growth trajectories, and future potential.
The global 3d printed medical devices market size will grow from $2.87 billion in 2022 to $3.57 billion in 2023 at a compound annual growth rate (CAGR) of 24.5%.
The major players covered in the global breast imaging devices market are Siemens Healthcare, GE Healthcare, Dilon Technologies Inc., Hologic Inc, Gamma Medica Inc Read More @ https://bit.ly/3dgN4Tt
The global breast imaging devices market is expected to grow from $3.461 billion in 2020 to $3.754 billion in 2021 at a compound annual growth rate (CAGR) of 8.5%. The market is expected to reach $6.091 billion in 2025 at a CAGR of 13%.
A recent report published by The Business Research Company on Breast Imaging Devices Market provides in-depth analysis of segments and sub-segments in the global as well as regional. https://bit.ly/2FoaQyi
Global Breast Imaging Devices Market by The Business Research Company is segmented as Tomosynthesis, Breast Ultrasound, Breast MRI, Mammography, Nuclear Imaging, Ionizing, Non Ionizing, Hospitals & Clinics, Breast Care Centers, Diagnostic Imaging Centers
This has encouraged the leaders in the healthcare industry to research & develop advanced devices focused on women health. It is projected to motivate the growth trends in the breast imaging market over the next few years.
24 Market Reports provides a complete data analysis of Global Magnetic Resonance Imaging Systems Market Research Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the global Magnetic Resonance Imaging Systems market is expected to reach high by the end of 2022.
This report on Circulating Tumor Cells (CTC) Technologies gives a market insight into technologies and services used for cancer detection. The market is analyzed by Cancer type into Prostate, Breast and Other; and by Function into Prognostics, Diagnostics and Therapy Management. See Full Report: http://bit.ly/1wnzBJd
Complete report on 3-D Breast Tomosynthesis market spread across 68 pages providing 3 company profiles and 2 tables and 33 figures is now available at http://www.marketreportsonline.com/contacts/purchase.php?name=563975.
A recent report published by The Business Research Company on Breast Imaging Devices Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/2FoaQyi
The non-ionizing breast imaging technologies segment is classified into five sub segments, namely, breast MRI, breast ultrasound, automated whole breast ultrasound (AWBU), breast thermography, and optical imaging.
The report on Breast Imaging Market by Infinium Global Research analyzes the Breast Imaging Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Breast Imaging Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Breast Imaging Market.
The report on Breast Imaging Market by Infinium Global Research analyzes over the period of 2016 to 2022. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Breast Imaging Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Breast Imaging Market.
The global breast cancer diagnostics market is expected to grow from $4.621 billion in 2020 to $5.466 billion in 2021 at a compound annual growth rate (CAGR) of 18.3%.
A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy.
A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy.
Big Market Research provides a new Report Package "Global Breast Imaging Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report At:http://www.bigmarketresearch.com/global-breast-imaging-2015-2019-market Global Breast Imaging Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Breast Imaging market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Know More At: http://www.bigmarketresearch.com/report-enquiry/169859
During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. See More: http://goo.gl/tW6DQL
Gene Therapy Immunology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. See Full Report @ http://bit.ly/1wAjdFi
This research analysis provides, a detailed information on breast imaging technological advancements in breast cancer diagnosis. This research report identifies and evaluates key advancements of breast screening modalities in development and approval stages. Patent analysis, investor analysis and investment opportunity evaluation along with multi-level criteria technology benchmarking are assessed within the breast imaging sector. Strategic recommendations for technology stakeholders are elaborately discussed in this research service.
The global fiducial markers market is expected to grow in the upcoming years due to rise in prevalence of cancer such as lung cancer, breast cancer and prostate cancer. Rise in the usage of radiotherapy in treatment of cancer is expected to boost the growth of the fiducial markers market. Fiducial marker is a device used in the radiotherapy treatment to mark the area for the surgery and to give accurate radiation dosage. The fiducial marker can mark the exact position of tumor and assist the doctor to give exact radiation dosage to the patient without harming the tissue. There are various types of fiducial markers available, which include polymer-based marker, metal-based marker among others. The fiducial marker technology can also provide 3D view of fiducials and give report for the exact diagnosis for the treatment.
According to the latest research report by IMARC Group, The United States medical imaging market size is projected to exhibit a growth rate (CAGR) of 2.90% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-medical-imaging-market
Cancer Biomarkers Market Information By Type (Genetic Biomarkers, Epigenetic Biomarkers, Proteomic Biomarkers, Glycoprotein Biomarkers), Disease Type, Profiling Technologies and Application: Forecast To 2027
Global ai in medical imaging market size is expected to reach $10.34 Bn by 2028 at a rate of 37.9%, segmented as by technology, deep learning, natural language processing (nlp), other technologies
Biomarkers Market research report focuses on the different types of biomarkers and their impact on various disease areas such as oncology (prostate, ovarian, breast and lung), neurology (stroke, brain tumor, neurodegenerative diseases), cardiology (coronary heart disease, heart failure, myocardial infarction), infectious diseases (GIT, respiratory tract infections) and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging, etc. See Full Report: http://bit.ly/1yXK1oQ
Global magnetic resonance imaging coils market size is expected to reach $18.42 bn by 2028 at a rate of 9.4% segmented as by type, radiofrequency coil, gradient coil
Global artificial intelligence in medical imaging market size is expected to reach $10.02 Bn by 2028 at a rate of 30.8%, segmented as by modality, computed tomography (ct) scan, magnetic resonance imaging (mri), x-rays, ultrasound, nuclear imaging
The global Mammography market, valued at US$ 2.3 Billion in 2023, is expected to exhibit a robust growth trajectory, expanding at a CAGR of 11.6% from 2024 to 2033, reaching US$ 6.9 Billion by the end of the forecast period. Digital Systems are anticipated to emerge as the highest revenue-generating segment, also witnessing a CAGR of 11.6%. Driving this growth are factors such as an aging population, a rise in hormonal imbalances and breast cancer cases, advancements in imaging technologies, and increased funding for breast cancer screening programs. However, barriers such as lack of awareness, patient discomfort, and potential adverse effects may hinder market growth.
According to the latest research report by IMARC Group, The global breast implant market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. More Info:- https://www.imarcgroup.com/breast-implant-market
Biopsy devices refer to the devices that are utilized for removing a piece of a sample or a tissue of cells from the body in order to analyse in the laboratory for presence of a disease. The devices are used among radiologists, interventional cardiologists and surgeons. The use of these biopsy devices varies depending on the type of organ under consideration.
All updated as on - From 2024–2031, the circulating tumor cell market is expected to expand from an initial valuation of $4.99 billion to $12.39 billion, representing a CAGR (compound annual growth rate) of 14.1%. In 2023, the market was valued at $4.14 billion.
The expanding healthcare industry and the elevating focus on patient safety are among the primary factors driving the whole imaging market. In addition to this, the rising prevalence of cancer, owing to the changing lifestyles, escalating smoking habits of consumers, genetic mutation, etc Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/whole--imaging-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Get Global Medical Image Processing Market (Application, Image Type, Technology and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021 market research report Published by Allied Market Research. The Report is available at $4515 for Single User
The global brachytherapy market is projected to be worth USD 548.8 Million by 2027, according to a current analysis by Emergen Research. The brachytherapy market is experiencing an increased demand attributed to its growing application in the treatment of cancer.
The global tumor ablation market is estimated to garner a revenue of around USD 5 billion by the end of 2033 by growing at a CAGR of ~14% over the forecast period, i.e., 2023 – 2033.